SEC Form 4 · accession 0001437749-26-025667
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James E Dentzer
Director
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000749647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2026 | A | 6,934 | $1.59 | A | 21,897 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Stock granted in lieu of cash for portion of board fees